OOIR: Observatory of International Research

Papers

(The H4-Index of Neurogastroenterology and Motility is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)

Article	Citations
Esophageal motility disorders on high‐resolution manometry: Chicago classification version 4.0^©	552
What is new in Chicago Classification version 4.0?	85
ESNM/ANMS consensus paper: Diagnosis and management of refractory gastro‐esophageal reflux disease	78
Body surface mapping of the stomach: New directions for clinically evaluating gastric electrical activity	70
Mucosal pathogenesis in gastro‐esophageal reflux disease	51
Chicago classification version 4.0^© technical review: Update on standard high‐resolution manometry protocol for the assessment of esophageal motility	48
Evidence for the presence and release of BDNF in the neuronal and non‐neuronal structures of the internal anal sphincter	47
Implications of SARS‐CoV‐2 infection for neurogastroenterology	47
Esophagogastric junction outflow obstruction	43
Functional gastrointestinal and somatoform symptoms five months after SARS‐CoV‐2 infection: A controlled cohort study	40
Chicago Classification update (V4.0): Technical review on diagnostic criteria for ineffective esophageal motility and absent contractility	39
Mast cell mediation of visceral sensation and permeability in irritable bowel syndrome	39
Postoperative ileus—An ongoing conundrum	38
Long‐term personalized low FODMAP diet improves symptoms and maintains luminal Bifidobacteria abundance in irritable bowel syndrome	37
Direct and indirect mechanisms by which the gut microbiota influence host serotonin systems	37
Evaluating esophageal motility beyond primary peristalsis: Assessing esophagogastric junction opening mechanics and secondary peristalsis in patients with normal manometry	36
Validation of secondary peristalsis classification using FLIP panometry in 741 subjects undergoing manometry	36
Deconstructing stigma as a barrier to treating DGBI: Lessons for clinicians	35
Emerging incidence trends of eosinophilic esophagitis over 25 years: Results of a nationwide register‐based pathology cohort	33
Standardized system and App for continuous patient symptom logging in gastroduodenal disorders: Design, implementation, and validation	33
Examining the optimal cutoff values of HADS, PHQ‐9 and GAD‐7 as screening instruments for depression and anxiety in irritable bowel syndrome	32
Current status of fecal microbiota transplantation for irritable bowel syndrome	32
United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis	31
Prevalence and risk factors for gastrointestinal symptoms after recovery from COVID‐19	31
Chronic constipation in adults: Contemporary perspectives and clinical challenges. 1: Epidemiology, diagnosis, clinical associations, pathophysiology and investigation	31

A novel scalable electrode array and system for non‐invasively assessing gastric function using flexible electronics	30
Increased prevalence of gastrointestinal symptoms and disorders of gut‐brain interaction during the COVID‐19 pandemic: An internet‐based survey	29
Principles and clinical methods of body surface gastric mapping: Technical review	29